<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04953273</url>
  </required_header>
  <id_info>
    <org_study_id>2020_ 01</org_study_id>
    <secondary_id>2020-A02591-38</secondary_id>
    <nct_id>NCT04953273</nct_id>
  </id_info>
  <brief_title>A Case Management Algorithm for Women Victims of Violence</brief_title>
  <acronym>VIGITRAUMA</acronym>
  <official_title>Effectiveness of a Case Management Algorithm on Clinical Outcome After Consultations Requested in a Clinical Forensic Medicine Unit by Female Victims of Violence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A considerable body of research has demonstrated that women who are victims of interpersonal&#xD;
      violence are at substantially elevated risk for the development of post-traumatic stress&#xD;
      disorder (PTSD). In France, victims can request a medico-legal examination in a clinical&#xD;
      forensic medicine unit. Although these units are also a place for initial psychological&#xD;
      examination, women often don't attend future scheduled appointments. Decision-making&#xD;
      algorithm using phone contact are effective in suicide prevention. Our aim is to assess the&#xD;
      effectiveness of case management algorithm using early phone contact compared to a control&#xD;
      group treated as usual on clinical outcome after consultation requested in a clinical&#xD;
      forensic medicine unit by female victims of violence.&#xD;
&#xD;
      Method: Prospective, multicenter, open-label, randomized controlled clinical trial, for women&#xD;
      victims of violence. Victims randomized in VIGITRAUMA group will be contacted by phone at 3&#xD;
      weeks after the consultation in a clinical forensic medicine unit, and a second phone call&#xD;
      can be done. If the subject is not contacted after the second phone call, he will receive a&#xD;
      postcard.&#xD;
&#xD;
      Control group will benefit from usual follow-up.&#xD;
&#xD;
      All the subjects included will be then evaluated at 3 months, 6 months and 1 year during a&#xD;
      phone call.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">July 2026</completion_date>
  <primary_completion_date type="Anticipated">July 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Outcome</measure>
    <time_frame>3 months</time_frame>
    <description>Rate of patients with a Clinical Global Impression (CGI) severity scale &lt; 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Outcome</measure>
    <time_frame>6 months</time_frame>
    <description>Rate of patients with a Clinical Global Impression (CGI) severity scale &lt; 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Outcome</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of patients with a Clinical Global Impression (CGI) severity scale &lt; 4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of post-traumatic stress disorder symptoms</measure>
    <time_frame>3 months, 6 months and 12 months</time_frame>
    <description>Post-traumatic stress disorder Checklist Scale-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General psychopathology</measure>
    <time_frame>3 months, 6 months and 12 months</time_frame>
    <description>French version of Mini International Neuropsychiatric Interview (DSM 5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of somatic symptoms</measure>
    <time_frame>3 months, 6 months and 12 months</time_frame>
    <description>Physical Health Questionnaire (PHQ-15)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical cost</measure>
    <time_frame>12 months</time_frame>
    <description>Nnumber of hospitalizations, consultations, and drugs consummation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Judicial outcome</measure>
    <time_frame>12 months</time_frame>
    <description>Number of days of temporary inability to work</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal ideation intensity</measure>
    <time_frame>12 months</time_frame>
    <description>The Beck Scale for Suicide Ideation (SSI) The Scale for Suicide Ideation (SSI; Beck, et al., 1979) is a brief 21-item scale that assesses the person's current intensity of attitudes, plans, and behaviors to commit suicide.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of suicide attempters</measure>
    <time_frame>12 months</time_frame>
    <description>Suicide risk</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">756</enrollment>
  <condition>Post-Traumatic Stress Disorder</condition>
  <condition>Violence-Related Symptom</condition>
  <arm_group>
    <arm_group_label>Vigitrauma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Contact by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call if necessary.&#xD;
If the subject is not contacted after the second phone call, he will receive a postcard.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vigitrauma</intervention_name>
    <description>Case management algorithm using early phone contact</description>
    <arm_group_label>Vigitrauma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women&#xD;
&#xD;
          -  18 years and older&#xD;
&#xD;
          -  Consultation requested in a clinical forensic medicine unit after being victim of&#xD;
             violence&#xD;
&#xD;
          -  The person was exposed to: death, threatened death, actual or threatened serious&#xD;
             injury, or actual or threatened sexual violence (PTSD criterion A - DSM -5)&#xD;
&#xD;
          -  With social insurance&#xD;
&#xD;
          -  Consent to participate to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Do no consent to participate to the study&#xD;
&#xD;
          -  Intrafamilial or intimate partner violence&#xD;
&#xD;
          -  Do not speak french&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Leroy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud Leroy, MD</last_name>
    <phone>+33 320444460</phone>
    <email>arnaud.leroy@chru-lille.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Laure Demarty</last_name>
    <phone>+33 320444145</phone>
    <email>anne-laure.demarty@chru-lille.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital, Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Cécile MANAOUIL</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gaetan PRISSETTE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital, Boulogne sur Mer</name>
      <address>
        <city>Boulogne-sur-Mer</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Stéphane CHOCHOIS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Grégoire MOUTEL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital, Creil</name>
      <address>
        <city>Creil</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Georges PATRU</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Laure CLINET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Yann DELANNOY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Gilles TOURNEL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital, Saint-Quentin</name>
      <address>
        <city>Saint-Quentin</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Fabien DELFORGE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital, Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Eric LAURIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>July 6, 2021</last_update_submitted>
  <last_update_submitted_qc>July 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post-Traumatic Stress Disorder</keyword>
  <keyword>Women Health</keyword>
  <keyword>Physical Abuse</keyword>
  <keyword>Forensic Medicine</keyword>
  <keyword>Case-Management Algorithm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

